hematology

Summary

Summary: A subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues.

Top Publications

  1. ncbi Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO)
    Michael Koenigsmann
    Hematology Oncology Departments, University Magdeburg, Germany
    Leuk Lymphoma 45:1821-7. 2004
  2. ncbi The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory
    Neil Harris
    University of Florida Shands Hospital Core Laboratory, Gainesville, Florida, USA
    Lab Hematol 11:47-61. 2005
  3. ncbi Nonhuman primates are relevant models for research in hematology, immunology and virology
    F Herodin
    Centre de Recherches du Service de Sante des Armees, 24 Avenue des Maquis du Gresivaudan, BP 87, 38702 La Tronche, France
    Eur Cytokine Netw 16:104-16. 2005
  4. ncbi Virtual microscopy: applications to hematology education and training
    Szu Hee Lee
    Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, SA, 5000, Australia
    Hematology 10:151-3. 2005
  5. pmc Presently available biosimilars in hematology-oncology: G-CSF
    Pere Gascon
    Division of Medical Oncology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
    Target Oncol 7:S29-34. 2012
  6. ncbi Laboratory reference values for healthy adults from southern Tanzania
    Elmar Saathoff
    Abteilung fuer Infektions und Tropenmedizin, Klinikum der Universitaet Muenchen, Munich, Germany
    Trop Med Int Health 13:612-25. 2008
  7. pmc CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa
    Etienne Karita
    Projet San Francisco PSF, Kigali, Rwanda
    PLoS ONE 4:e4401. 2009
  8. ncbi Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)
    M Ruhnke
    Department of Internal Medicine, Charite University Medicine, Campus Charite Mitte, Berlin, Germany
    Ann Oncol 23:823-33. 2012
  9. ncbi Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
    V Conter
    Department of Pediatrics, University of Milano Bicocca, Ospedale S Gerardo, Monza, Italy
    Leukemia 24:255-64. 2010
  10. pmc Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
    Oliver A Cornely
    Klinikum der Universität zu Köln, Klinik I für Innere Medizin Zentrum für Klinische Studien BMBF 01KN0706, Koln, Germany
    Haematologica 94:113-22. 2009

Detail Information

Publications266 found, 100 shown here

  1. ncbi Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO)
    Michael Koenigsmann
    Hematology Oncology Departments, University Magdeburg, Germany
    Leuk Lymphoma 45:1821-7. 2004
    ..Dose level 1 with 30 mg/m2/d of both drugs on days 1 to 3 was defined as the recommended dose. Despite unfavorable prognostic features (histologic subtype, stage of disease, pretreatment) response rates were good with this regimen...
  2. ncbi The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory
    Neil Harris
    University of Florida Shands Hospital Core Laboratory, Gainesville, Florida, USA
    Lab Hematol 11:47-61. 2005
    The ADVIA 2120 Hematology System was recently released by Bayer HealthCare, Diagnostics Division, as a bench-top analyzer designed for medium- to large-volume laboratories...
  3. ncbi Nonhuman primates are relevant models for research in hematology, immunology and virology
    F Herodin
    Centre de Recherches du Service de Sante des Armees, 24 Avenue des Maquis du Gresivaudan, BP 87, 38702 La Tronche, France
    Eur Cytokine Netw 16:104-16. 2005
    ..The similarity of monkeys to humans has been used to investigate pathophysiological mechanisms in hematology, immunology and virology...
  4. ncbi Virtual microscopy: applications to hematology education and training
    Szu Hee Lee
    Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, SA, 5000, Australia
    Hematology 10:151-3. 2005
  5. pmc Presently available biosimilars in hematology-oncology: G-CSF
    Pere Gascon
    Division of Medical Oncology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
    Target Oncol 7:S29-34. 2012
    ..Ultimately, only clinical trials and effective post-marketing pharmacovigilance will provide definitive evidence that a biosimilar is comparable to the originator-reference product in terms of efficacy and safety...
  6. ncbi Laboratory reference values for healthy adults from southern Tanzania
    Elmar Saathoff
    Abteilung fuer Infektions und Tropenmedizin, Klinikum der Universitaet Muenchen, Munich, Germany
    Trop Med Int Health 13:612-25. 2008
    ..To define and discuss reference ranges for commonly determined laboratory parameters in healthy adults from southern Tanzania...
  7. pmc CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa
    Etienne Karita
    Projet San Francisco PSF, Kigali, Rwanda
    PLoS ONE 4:e4401. 2009
    ..The objective of this study was to establish clinical laboratory reference intervals for 25 hematology, immunology and biochemistry values among healthy African adults typical of those who might join a clinical trial...
  8. ncbi Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)
    M Ruhnke
    Department of Internal Medicine, Charite University Medicine, Campus Charite Mitte, Berlin, Germany
    Ann Oncol 23:823-33. 2012
    ..The AGIHO presents recommendations for the diagnosis of IFIs with risk-adapted screening concepts for febrile episodes in patients with haemato-oncological disorders...
  9. ncbi Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
    V Conter
    Department of Pediatrics, University of Milano Bicocca, Ospedale S Gerardo, Monza, Italy
    Leukemia 24:255-64. 2010
    ..82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia (ALL) of the Italian Association of Pediatric Hematology and Oncology (AIEOP)...
  10. pmc Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
    Oliver A Cornely
    Klinikum der Universität zu Köln, Klinik I für Innere Medizin Zentrum für Klinische Studien BMBF 01KN0706, Koln, Germany
    Haematologica 94:113-22. 2009
    ..Fluconazole 400 mg/d is recommended in allogeneic stem cell recipients until development of graft versus host disease only (Level A I). Aerosolized liposomal amphotericin B is recommended during prolonged neutropenia (Level B II)...
  11. ncbi Anemia management in oncology and hematology
    Jerry L Spivak
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21210, USA
    Oncologist 14:43-56. 2009
    ..An update on the management of anemia in oncology, the potential adverse events of ESAs, the benefits and risks of transfusions, and QoL are discussed in this paper...
  12. ncbi Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Florian Weissinger
    Klinik fur Innere Medizin, Hämatologie Onkologie und Palliativmedizin, Evangelisches Krankenhaus Bielefeld, Schildescher Str 99, 33611 Bielefeld, Germany
    Ann Hematol 91:1161-74. 2012
    ..In this review we discuss all aspects of infections after autologous stem transplantation, including epidemiology, diagnostics, therapeutic algorithms, prophylaxis and supportive therapy...
  13. ncbi Parainfluenza virus type 3 infections in a hematology unit
    U Hohenthal
    Department of Medicine, Turku University Central Hospital, Finland
    Bone Marrow Transplant 27:295-300. 2001
    ..or autologous stem cell transplantation) identified as having PIV3 infection during a 2-month period in a Hematology Unit. Four patients with infiltrates on chest radiograph received intravenous ribavirin therapy; all survived...
  14. ncbi The role of Smad signaling in hematopoiesis and translational hematology
    U Blank
    Division of Molecular Medicine and Gene Therapy, Laboratory Medicine, Lund Stem Cell Center, Lund University Hospital, Lund, Sweden
    Leukemia 25:1379-88. 2011
    ..In this review, we bring the Smad-signaling pathway into focus, chronicling key concepts and recent advances with respect to TGF-β-superfamily signaling in normal and leukemic hematopoiesis...
  15. pmc High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology
    Edus H Warren
    Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Blood 122:19-22. 2013
    ....
  16. ncbi Comparison of four hematology analyzers, CELL-DYN Sapphire, ADVIA 120, Coulter LH 750, and Sysmex XE-2100, in terms of clinical usefulness
    S H Kang
    Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea
    Int J Lab Hematol 30:480-6. 2008
    ..leukocyte distribution classification, morphologic classification, and morphologic flags) of the following four hematology analyzers: CELL-DYN Sapphire (CD-Sapphire) (Abbott Diagnostics, Santa Clara, CA, USA), ADVIA 120 (Bayer ..
  17. ncbi Implementing virtual microscopy improves outcomes in a hematology morphology course
    Mauri S Brueggeman
    Center for Allied Health Programs, University of Minnesota, Minneapolis, MN 55455, USA
    Clin Lab Sci 25:149-55. 2012
    ..the efficacy of virtual microscopy as the primary mode of laboratory instruction in undergraduate level clinical hematology teaching...
  18. ncbi Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice
    Karon Abe
    Division of Public Health, Georgia Department of Human Resources, Atlanta, GA, USA
    Infect Control Hosp Epidemiol 28:1311-3. 2007
    ..Though we did not identify the source of the organism, our findings support the hypothesis that cross-contamination of multidose medications through the use of the same needle and syringe was a contributing factor...
  19. pmc First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults
    Hamid Jalal
    Clinical Microbiology and Public Health Laboratory, Addenbrooke s Hospital, Cambridge, Hills Road, Cambridge CB2 2QW, United Kingdom
    J Clin Microbiol 43:2575-80. 2005
    Numerous outbreaks of adenovirus infection from different types of health care settings, except a hematology unit, have been reported...
  20. ncbi Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update
    J Douglas Rizzo
    Medical College of Wisconsin, Milwaukee, WI, USA
    Blood 111:25-41. 2008
    To update the American Society of Clinical Oncology/American Society of Hematology (ASCO/ASH) recommendations for the use of epoetin...
  21. ncbi Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles
    Athanasia D Panopoulos
    Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA
    Curr Opin Hematol 19:256-60. 2012
    ..of this review is to discuss the recent key developments and remaining limitations in the stem cell and hematopoietic fields toward the goal of translating induced pluripotent stem cell (iPSC) technologies into the hematology clinic.
  22. ncbi RNA interference (RNAi) in hematology
    M Scherr
    Department of Hematology and Oncology, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Ann Hematol 83:1-8. 2004
    ....
  23. ncbi The role of chromosome 21 in hematology and oncology
    Christa Fonatsch
    Institute of Human Genetics, Medical University of Vienna, Währinger Strasse 10, Vienna, Austria
    Genes Chromosomes Cancer 49:497-508. 2010
    ..Finally, the nature and function of specific genes, like RUNX1, TMPRSS2, and TFF, located in 21q, and their role in tumorigenesis will be exemplified...
  24. pmc Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach
    Michelle R Ananda-Rajah
    Infectious Diseases Unit, Alfred Health, Commercial Road, Melbourne, Victoria 3004, Australia
    Antimicrob Agents Chemother 55:1953-60. 2011
    ..Consumption of costly antifungal drugs may be a novel resource metric with wider generalizability than cost alone...
  25. ncbi Is the blood basophil count sufficiently precise, accurate, and specific?: three automated hematology instruments and flow cytometry compared
    Erik K Amundsen
    Blood cell research group, Department of Medical Biochemistry, Oslo University Hospital, Ullevaal, Oslo, Norway
    Am J Clin Pathol 137:86-92. 2012
    We compared the performance of the basophil count of 3 hematology instruments with a flow cytometric method (FCM) in which CD123 and CD193 were used as basophil markers...
  26. ncbi Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations
    Henriette P Sennels
    Department of Clinical Biochemistry, Faculty of Health Sciences, Bispebjerg Hospital, Copenhagen, Denmark
    Scand J Clin Lab Invest 71:532-41. 2011
    To evaluate the influence of time of day on the circulating concentrations of 21 hematology parameters.
  27. ncbi Evaluation of the impedance analyzer PocH-100iV Diff for analysis of canine and feline blood
    Natali B Bauer
    Department of Veterinary Clinical Sciences, Clinical Pathology and Clinical Pathophysiology, Justus Liebig University, Giessen, Germany
    Vet Clin Pathol 41:194-206. 2012
    An automated impedance-based in-house hematology analyzer, the PocH-100iV Diff, which provides a 3-part leukocyte differential count that includes eosinophils, recently has been introduced.
  28. ncbi The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
    Antonio Curti
    Department of Hematology and Oncological Sciences L and A Seràgnoli, University of Bologna and Stem Cell Research Center, Azienda Ospedaliero Universitaria Policlinico S Orsola Malpighi, Bologna, Italy
    Blood 113:2394-401. 2009
    ..In this review, the role of IDO in the induction of immunologic tolerance is addressed with a specific focus on its recently discovered effect on hematologic malignancies...
  29. pmc Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (D
    S Neumann
    Department of Hematology and Oncology, Georg August University Gottingen, Robert Koch Str 40, 37075, Gottingen, Germany
    Ann Hematol 92:433-42. 2013
    ..and approved in a consensus conference of the Infectious Disease Working Party of the German Society of Hematology and Oncology (AGIHO). Antibacterial prophylaxis has led to a reduction of febrile events and infections...
  30. ncbi Artifactual changes in canine blood following storage, detected using the ADVIA 120 hematology analyzer
    Tommaso Furlanello
    Clinical Veterinaria Privata San Marco and Laboratorio d Analisi Veterinarie, San Marco, Padova, Italy
    Vet Clin Pathol 35:42-6. 2006
    ..Artifactual changes in blood may occur as a consequence of delayed analysis and may complicate interpretation of CBC data...
  31. pmc Factors associated with the career choices of hematology and medical oncology fellows trained at academic institutions in the United States
    Leora Horn
    Vanderbilt Ingram Cancer Center, Nashville, TN, USA
    J Clin Oncol 29:3932-8. 2011
    Factors that influence hematology-oncology fellows' choice of academic medicine as a career are not well defined...
  32. ncbi An assessment of the current state of palliative care education in pediatric hematology/oncology fellowship training
    Michael Roth
    Children s Hospital at Montefiore, Bronx, New York 10467, USA
    Pediatr Blood Cancer 53:647-51. 2009
    ..This has led to the recommendation that increased palliative care training for physicians taking care of terminally ill pediatric patients is needed...
  33. ncbi Hematology tests of blood anticoagulated with magnesium sulphate
    Hiroshi Kondo
    Department of Clinical Laboratory Science, Osaka Prefecture College of Health Sciences, Osaka, Japan
    Southeast Asian J Trop Med Public Health 33:6-9. 2002
    Venous blood treated with magnesium sulphate (MgSO4) at blood collection was used for hematology tests...
  34. ncbi Present and future of hematology and stem cell transplantation in Morocco
    S Benchekroun
    Service d Hématologie et Oncologie Pédiatrique SHOP, Casablanca, Morocco
    Bone Marrow Transplant 42:S106-S108. 2008
    The first hematology department in Morocco was created in Casablanca in 1980 and it is still the only public facility where adult patients can be treated for hematological diseases...
  35. ncbi Measurement of total and differential white blood cell counts in synovial fluid by means of an automated hematology analyzer
    Hiroyuki Sugiuchi
    Department of Laboratory Medicine, Kumamoto University Medical School, Kumamoto, Japan
    J Lab Clin Med 146:36-42. 2005
    ..white blood cell (WBC) counts by pretreating synovial fluid with hyaluronidase and using an automated hematology analyzer...
  36. ncbi Norwegian healthcare professionals' perceptions of patient knowledge and involvement as basis for decision making in hematology
    Frode Heldal
    Department of Economics and Technology Management, Norwegian University of Science and Technology in Trondheim, Norway
    Oncol Nurs Forum 36:E93-8. 2009
    ..To investigate how healthcare professionals relate to patients with different levels of knowledge and involvement in their disease and treatment...
  37. ncbi An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic
    Alexandre Macedo de Oliveira
    Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Ann Intern Med 142:898-902. 2005
    ..The authors suspected a health care-associated HCV outbreak after the report of 4 HCV infections among patients at the same hematology/oncology clinic.
  38. ncbi Reference values for clinical chemistry and clinical hematology parameters in cynomolgus monkeys
    Henk Jan Schuurman
    Imutran Ltd A Novartis Pharma AG Company, Cambridge, UK
    Xenotransplantation 12:72-5. 2005
    In vivo xenotransplantation modeling in large animal species is often performed in nonhuman primates, including baboons. For proper data interpretation, reference values for clinical chemistry and hematology are required.
  39. ncbi Evaluation of the Sysmex Xe-2100 hematology analyzer in hospital use
    Danièle Nakul-Aquaronne
    Laboratoire Central d Hématologie, hopital de Cimiez, Nice, France
    J Clin Lab Anal 17:113-23. 2003
    The Sysmex XE-2100 (Sysmex Corp. Kobe, Japan) is a latest-generation hematology analyzer. Its optical and electrical measuring technology is improved by the addition of flux cytometry, fluorescence, and differential lysis...
  40. ncbi Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers
    Alexander Kratz
    Division of Laboratory Medicine, Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston, USA
    Arch Pathol Lab Med 131:293-6. 2007
    ..The effects of specimen transport through a pneumatic tube system on laboratory results obtained with such modern instruments are unclear...
  41. ncbi Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation
    Giovanni Barosi
    Laboratorio di Epidemiologia Clinica, IRCCS Policlinico S Matteo, Pavia, Italy
    Haematologica 90:1236-57. 2005
    The Italian Society of Hematology (SIE) and the two affiliated societies (SIES and GITMO) commissioned a project to develop clinical practice guidelines for the treatment of nodal indolent non-Hodgkin's lymphomas (NHL)...
  42. ncbi Autoimmunity and malignancy in hematology--more than an association
    Martin Stern
    Division of Experimental Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Policlinico Monteluce, Perugia, Italy
    Crit Rev Oncol Hematol 63:100-10. 2007
    ....
  43. ncbi Reference values of clinical chemistry and hematology parameters in rhesus monkeys (Macaca mulatta)
    Younan Chen
    West China Hospital, Sichuan University, Chengdu, China
    Xenotransplantation 16:496-501. 2009
    Rhesus monkey models are valuable to the studies of human biology. Reference values for clinical chemistry and hematology parameters of rhesus monkeys are required for proper data interpretation.
  44. ncbi Cell analysis in cerebrospinal fluid (CSF) using Sysmex® hematology analyzers XT-4000i and XE-5000: evaluation with CSF controls of the Joint German Society for Clinical Chemistry and Laboratory Medicine (DGKL)
    Tilmann O Kleine
    Institut für Laboratoriumsmedizin und Pathobiochemie, Molekulare Diagnostik, Referenzlabor für Liquordiagnostik, Universitätsklinikum Giessen und Marburg, 35043 Marburg, Germany
    Cytometry A 81:255-64. 2012
    In cerebrospinal fluid (CSF) analysis, hematology analyzers (HAs) Sysmex® XT-4000i and XE-5000, equipped with flow cytometry (FCM), were used to count cells and differentiate leukocytes into mononuclear and polymorphonuclear cells (MNCs, ..
  45. ncbi Molecular and chemical characterization of blood cells by infrared spectroscopy: a new optical tool in hematology
    Kan Zhi Liu
    Institute for Biodiagnostics, National Research Council of Canada, 435 Ellice Avenue, Winnipeg, MB, Canada R3B 1Y6
    Blood Cells Mol Dis 35:404-12. 2005
    Infrared (IR) spectroscopy has made important contributions to the arena of hematology in the past decade. The normal physiology and pathologic modifications of the three cellular elements in blood, i.e...
  46. ncbi Isolation of Trichosporon in a hematology ward
    Gabriella Pini
    Department of Public Health, University of Florence, Florence, Italy
    Mycoses 48:45-9. 2005
    During mycologic monitoring of the air in a hematology ward, we found massive air contamination caused by Trichosporon asahii, both in the room where neutropenic patients were staying and the corridor immediately outside the room...
  47. ncbi Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "lung injury by bortezomib" joint committee of the Japanese society of hematology and the Japanese society of
    Akihiko Gotoh
    The Lung Injury by Bortezomib Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology, Japan
    Int J Hematol 84:406-12. 2006
    ..general use in Japan and is imported by attending physicians on the request of patients, The Japanese Society of Hematology and The Japanese Society of Clinical Hematology sent urgent questionnaires to the councilors of both societies ..
  48. pmc Zebrafish in hematology: sushi or science?
    Duncan Carradice
    Walter and Eliza Hall Institute of Medical Reserch, Department of Medical Biology, University of Melbourne, and Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Parkville, Australia
    Blood 111:3331-42. 2008
    After a decade of the "modern era" of zebrafish hematology research, what have been their major contributions to hematology and what challenges does the model face? This review argues that, in hematology, zebrafish have demonstrated their ..
  49. ncbi The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology
    K Ruzicka
    Department of Laboratory Medicine, University of Vienna, Austria
    Arch Pathol Lab Med 125:391-6. 2001
    CONTEXT: The new hematology analyzer Sysmex XE-2100 (TOA Medical Electronics, Kobe, Japan) has a novel, combined, white blood cell differential technology and a special reagent system to enumerate nucleated red blood cells...
  50. ncbi Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Angelika Böhme
    ONKOLOGIKUM, Frankfurt am Museumsufer, Frankfurt, Germany
    Ann Hematol 88:97-110. 2009
    ..The Infectious Diseases Working Party of the German Society of Hematology and Oncology here presents its 2008 recommendations discussing the dos and do-nots, as well as the problems and ..
  51. ncbi Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients
    Steffen Engelhart
    Institute of Hygiene and Public Health, University of Bonn, Germany
    Infect Control Hosp Epidemiol 23:244-8. 2002
    To determine the incidence of nosocomial infections (NIs) and fever of unknown origin among adult hematology-oncology patients.
  52. ncbi Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Angelika Böhme
    Medizinische Klinik III, J W Goethe Universitat, Theodor Stern Kai 7, 60590, Frankfurt Main, Germany
    Ann Hematol 82:S133-40. 2003
    ..These guidelines offer actual standards and discussions on the treatment of oropharyngeal and esophageal candidiasis, invasive candidiasis, cryptococcosis and mould infections...
  53. ncbi Protein-protein interactions in hematology and phage display
    B P Mullaney
    Department of Laboratory Medicine, University of California at San Francisco, San Francisco, Calif, USA
    Exp Hematol 29:1136-46. 2001
    ..interactions, and clonal and immunologic selection, is used increasingly to advance experimental and clinical hematology. Phage display is based on the ability of bacteriophage to present engineered proteins on their surface coat...
  54. ncbi Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial
    Neil Harris
    University of Florida Shands Hospital Core Laboratory, Gainesville, Florida, USA
    Lab Hematol 11:62-70. 2005
    ..We concluded that the ADVIA 2120 system has clinically equivalent performance to the ADVIA 120 system...
  55. ncbi Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
    Emanuele Angelucci
    Hematology Department and BMT Unit, Cancer Center Armando Businco, viale Edward Jenner, 09121 Cagliari, Italy
    Haematologica 93:741-52. 2008
    ..To assure appropriate use of these new health technologies, the Italian Society of Hematology appointed a panel of experts to produce clinical practice-guidelines for the management of iron overload in ..
  56. ncbi Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I
    Scott C Howard
    International Outreach Program and Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
    Pediatr Blood Cancer 48:364-9. 2007
    ..In 1996, the Monza International School of Pediatric Hematology/Oncology (MISPHO) was founded in an attempt to narrow this survival gap...
  57. ncbi Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit
    Kathryn Field
    Department of Clinical Hematology and Medical Oncology, Geelong Hospital, Barwon Health, Geelong, Vic, 3220, Australia
    Infect Control Hosp Epidemiol 28:610-3. 2007
    ..are few Australian data on the incidence of catheter-associated bloodstream infection (BSI) among patients in hematology-oncology units...
  58. ncbi The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns
    Michael B Streiff
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Blood 99:1144-9. 2002
    ..To determine practice patterns in the management of PV, a random sample of the US American Society of Hematology (ASH) membership was surveyed. Thirty-three percent of 3000 surveys were returned...
  59. pmc Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit
    Hamid Jalal
    Centre for Virology, Department of Infection, Royal Free and University College Medical School UCL Campus, Windeyer Institute of Medical Sciences, London W1T 4JF, United Kingdom
    J Clin Microbiol 45:1690-6. 2007
    ..outbreak of respiratory syncytial virus (RSV) and parainfluenza type 3 (PIV-3) infections occurred on an adult hematology unit...
  60. ncbi Training in difficult conversations: a national survey of pediatric hematology-oncology and pediatric critical care physicians
    Leslie Kersun
    The Children s Hospital of Philadelphia, Pennsylvania 19104, USA
    J Palliat Med 12:525-30. 2009
    ..In pediatric oncology and critical care, physicians give difficult news, including discussions regarding palliative care and comfort measures, but there are minimal data regarding fellowship program preparation for this task...
  61. ncbi Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients
    Nila Suntharam
    Department of Medicine, Division of Infectious Diseases, Northwestern University Medical School, Chicago, IL, USA
    Diagn Microbiol Infect Dis 43:183-8. 2002
    The incidence of VRE has increased dramatically and hematology-oncology patients are at high risk for acquisition of colonization and development of infection...
  62. ncbi Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
    Maura Brugiatelli
    Divisione di Ematologia, Azienda Ospedaliera Papardo, Messina, Italy
    Haematologica 91:1662-73. 2006
    The Italian Society of Hematology (SIE) and two affiliate societies (SIES and GITMO) commissioned a project to develop clinical practice guidelines for the treatment of chronic lymphocytic leukemia (CLL).
  63. ncbi Laboratory productivity and the rate of manual peripheral blood smear review: a College of American Pathologists Q-Probes study of 95,141 complete blood count determinations performed in 263 institutions
    David A Novis
    Department of Pathology, Wentworth Douglass Hospital, Dover, NH, USA
    Arch Pathol Lab Med 130:596-601. 2006
    Automated laboratory hematology analyzers are capable of performing differential counts on peripheral blood smears with greater precision and more accurate detection of distributional and morphologic abnormalities than those performed by ..
  64. ncbi Legal and ethical issues relating to use of complementary therapies in pediatric hematology/oncology
    Michael H Cohen
    Harvard Medical School, Harvard School of Public Health, Law Offices, 1811 NW 51 St, Suite 1289, Fort Lauderdale, FL 33309, USA
    J Pediatr Hematol Oncol 28:190-3. 2006
    ..asked to advise pediatric patients and their families concerning integration into conventional care (including hematology and oncology) of complementary and alternative medical (CAM) therapies such as chiropractic, massage therapy, ..
  65. pmc Hembase: browser and genome portal for hematology and erythroid biology
    Sung Ho Goh
    Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, MD 20892, USA
    Nucleic Acids Res 32:D572-4. 2004
    ..Hembase provides interested scientists and clinical hematologists with a genome-based approach toward the study of erythroid biology...
  66. ncbi Malaria detection with the Sysmex XE-2100 hematology analyzer using pseudoeosinophilia and abnormal WBC scattergram
    Hee Jin Huh
    Department of Laboratory Medicine, College of Medicine, Dongguk University, Goyang, Republic of Korea
    Ann Hematol 87:755-9. 2008
    Recent investigation using the Sysmex XE-2100 hematology analyzer (Sysmex Corporation, Japan) has demonstrated erroneously high eosinophil counts and abnormal white blood cell (WBC) scattergrams in malaria cases...
  67. ncbi Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology
    Marcela Zemkova
    The Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden
    New Microbiol 30:423-30. 2007
    ..996, p = 0.005) and in the community (r = 0.878, p = 0.029). Results of this study shows the impact of fluoroquinolone utilization on Escherichia coli resistance, and support the need of controlled use of these effective antibiotics...
  68. pmc Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation
    Enrica Morra
    Division of Hematology, Niguarda Ca Granda Hospital, Milan, Italy
    Haematologica 94:102-12. 2009
    As many options are now available to treat patients with de novo acute myeloid leukemia, the Italian Society of Hematology and two affiliated societies (SIES and GITMO) commissioned project to an Expert Panel aimed at developing clinical ..
  69. ncbi Special considerations in the evaluation of the hematology and hemostasis of mutant mice
    B D Car
    DuPont Pharmaceuticals Company, Stine Haskell Research Center, Newark, DE 19714 0030, USA
    Vet Pathol 38:20-30. 2001
    ..Mice with deficiencies in hemostatic and fibrinolytic system proteins are discussed, and the investigation of their phenotypes is reviewed...
  70. ncbi Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    M Ruhnke
    Dept of Medicine, Div Onkology Hematology, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Schumannstrasse 20 21, 10117, Berlin, Germany
    Ann Hematol 82:S141-8. 2003
    ..The AGIHO presents recommendations for the diagnosis of invasive fungal infections with risk-adapted screening concepts for the neutropenic and febrile episodes of patients with hemato-oncological disorders...
  71. ncbi History of pediatric hematology oncology
    Howard A Pearson
    Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Pediatr Res 52:979-92. 2002
    Pediatric Hematology Oncology as a specialty was possible because of the evolution of the science of Hematology, which developed microscopy for describing blood cell morphology and methods for quantitation of these elements...
  72. ncbi Application of flow cytometric techniques to veterinary clinical hematology
    Douglas J Weiss
    Department of Veterinary Pathobiology, University of Minnesota, St Paul, MN 55108, USA
    Vet Clin Pathol 31:72-82. 2002
    ..Flow cytometers in current use include stand-alone instruments and cytometers incorporated into hematology analyzers...
  73. ncbi Producing accurate platelet counts for platelet rich plasma: validation of a hematology analyzer and preparation techniques for counting
    Jennifer E Woodell-May
    Biomet, Inc Warsaw, Indiana 46581, USA
    J Craniofac Surg 16:749-56; discussion 757-9. 2005
    ..Therefore, the purpose of this study was to validate an automated hematology analyzer, the Cell-Dyn 3700, to accurately count platelets in concentration ranges of approximately 2,000,000-4,..
  74. ncbi Nuclear terrorism: the role of hematology in coping with its health consequences
    Theodor M Fliedner
    Radiation Medicine Research Group, University of Ulm, Faculty of Medicine, Helmholtzstrasse 20, D 89081 Ulm, Germany
    Curr Opin Hematol 13:436-44. 2006
    ....
  75. ncbi Zebrafish: from hematology to hydrology
    P Jagadeeswaran
    Department of Biological Sciences, University of North Texas, Denton, TX 76203, USA
    J Thromb Haemost 5:300-4. 2007
    ..Recently, we have discovered that fish secrete proteases, which participate in hemostasis and may have direct relevance in humans. Future work to identify most of the players in thrombus formation is underway...
  76. ncbi Proteomics techniques and their application to hematology
    Ileana M Cristea
    Department of Biomolecular Sciences, University of Manchester Institute of Science and Technology, Manchester, United Kingdom
    Blood 103:3624-34. 2004
    ..This review presents an analysis of the present and future impact of these proteomic technologies with emphasis on relative quantification for hematologic research giving an appraisal of their potential benefits...
  77. ncbi Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe
    Irene Roberts
    Haematologica 92:865-71. 2007
  78. ncbi Use of the Advia 120 hematology analyzer in the differential cytologic analysis of biological fluids (cerebrospinal, peritoneal, pleural, pericardial, synovial, and others)
    C Aulesa
    Unidad de Laboratorios, Ciudad Sanitaria Valle de Hebron, Barcelona, Spain
    Lab Hematol 9:214-24. 2003
    ..demand for assistance is a challenge for the laboratory, and the challenge has been met by the automated hematology area...
  79. ncbi Pediatric workforce: a look at pediatric hematology-oncology data from the American Board of Pediatrics
    Linda A Althouse
    American Board of Pediatrics, Chapel Hill, North Carolina 27514, USA
    J Pediatr 148:436-437. 2006
  80. ncbi [Hematology and Child Oncology at the Clinic of Children Diseases of Clinical Hospital No 14 at the Medical University, Lodz, Poland]
    Elizbieta Zielińska
    Med Wieku Rozwoj 10:51-2. 2006
  81. ncbi [History of the Department of the Hematology and Oncology at the Children States Hospital, Kielce, Poland]
    Katarzyna Litwiniszyn-Krzewicka
    Med Wieku Rozwoj 10:65-6. 2006
  82. ncbi Academic training pathways in pediatric hematology-oncology
    Kathleen M Sakamoto
    Division of Hematology Oncology, Mattel Children s Hospital, David Geffen School of Medicine, Los Angeles, California 90095 1752, USA
    Pediatr Blood Cancer 47:239-41. 2006
  83. ncbi [Center of Child Hematology and Oncology, Gdansk, Poland]
    Anna Balcerska
    Med Wieku Rozwoj 10:71. 2006
  84. ncbi [Characteristics of the Children Hematology and Oncology Clinic, Krakow, Poland]
    Walentyna Balwierz
    Klinika Onkologii i Hematologii Dzieciecej, Polsko Amerykanskiego Instytutu Pediatrii, Collegium Medicum, Uniwersytetu Jagiellonskiego
    Med Wieku Rozwoj 10:53-61. 2006
  85. ncbi [History of Hematology "Dzialdowski" - my own account]
    Maria Ochocka
    Med Wieku Rozwoj 10:87-9. 2006
  86. ncbi [History of the Department and Pediatric Clinic, Hematology and Oncology of the Medical Academy L Rygier in Bydgoszcz (previous name: the Department and Clinic of Children Diseases)]
    Mariusz Wysocki
    Med Wieku Rozwoj 10:81-3. 2006
  87. ncbi [History of the Pediatric Clinic, the Clinic of Hematology and Child Oncology and the Clinic of Child Oncology and Transplantation at the Medical University, Poznan, Poland, from 1972-2006]
    Jacek Wachowiak
    Med Wieku Rozwoj 10:67-70. 2006
  88. ncbi [History of the Child Clinic of Bone Marrow Transplantation, Hematology and Oncology, Wroclaw, Poland]
    Alicja Chybicka
    Med Wieku Rozwoj 10:73-5. 2006
  89. ncbi Clinical advances in pediatric hematology & oncology: cooperative group research
    Gregory H Reaman
    The George Washington University School of Medicine and Health Sciences, USA
    Clin Adv Hematol Oncol 3:133-5. 2005
  90. ncbi An interview with Purificación García de Miguel, chief of Haematology-Oncology and the Paediatric Bone Marrow Transplantation Unit of the Hospital La Paz, Madrid, and President of the Spanish Society of Paediatric Oncology (SEOP). Interview
    Purificación García de Miguel
    Clin Transl Oncol 10:187-8. 2008
  91. ncbi Consensus on a core curriculum in American training programs in pediatric hematology-oncology: a report from the ASPHO Training Committee
    C Hastings
    Children s Hospital and Research Center Oakland, Department of Hematology Oncology, Oakland, California 94609, USA
    Pediatr Hematol Oncol 24:503-12. 2007
    The Training Committee (TC) of the American Society of Pediatric Hematology/Oncology created a foundation of common goals and objectives that could provide a structure for fellowship programs...
  92. ncbi [Experience with the G-DRG-system five years after its introduction, as assessed by the Society of Pediatric Oncology and Hematology (GPOH)]
    U Gobel
    Klin Padiatr 219:303-5. 2007
  93. ncbi [Supporting research in pediatric oncology and hematology]
    H Jurgens
    Klin Padiatr 219:125-6. 2007
  94. ncbi [Position paper by the Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) and the Deutsche Leukämie-Forschungshilfe (DLFH) on psycho-social care for pediatric oncology and hematology patients in hospital]
    B Schreiber-Gollwitzer
    Kinderklinik Dritter Orden, Munchen
    Klin Padiatr 219:368-71. 2007
    ..The following article gives a short survey of this position paper and provides insight into the goals, conditions and outcomes of psychosocial care in pediatric oncology and hematology.
  95. ncbi Specializing in pediatric hematology and oncology
    M Brooke Beavers
    Texas Children s Hospital, Houston 77030 2316, USA
    Am J Health Syst Pharm 64:812-3. 2007
  96. ncbi [Diagnostic and differential-diagnostic considerations regarding the assessment of children's reactions within the scope of psychosocial care in paediatric oncology and haematology]
    B Schreiber-Gollwitzer
    Kinderklinik Dritter Orden, Munchen
    Klin Padiatr 219:372-9. 2007
    ..This opinion is increasingly gaining acceptance in pediatric oncology...
  97. ncbi [Assessment of staffing and infrastructures of paediatric oncology and haematology centres in Germany]
    R Herold
    Kompetenznetz Pädiatrische Onkologie und Hämatologie, Berlin
    Klin Padiatr 219:380-90. 2007
    ..Starting with the largest patient numbers, 53 German centres were included, which cared for at least 10 patients under the age of 15 years with a newly diagnosed malignant disease per year...
  98. ncbi Lack of a uniform approach to clinical research training for hematology oncology fellows
    Malek Safa
    University of Cincinnati, Ohio 45267 0501, USA
    J Cancer Educ 21:166-8. 2006
    Preparing hematology/oncology clinical investigators is a major challenge for the advancement of translational cancer research. The goal of this study was to evaluate the experience of fellowship programs in this area.
  99. ncbi Monoclonal antibodies in clinical hematology and oncology
    Dirk Nagorsen
    Charite Universitatsmedizin Berlin, Department of Hematology and Oncology, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
    Curr Opin Investig Drugs 8:996-1001. 2007
    ..While mAbs may not be the 'magic bullets' that many researchers had hoped for, they are nevertheless becoming an indispensable pillar of tumor therapy...
  100. ncbi Evaluation of a pediatric palliative care educational workshop for oncology fellows
    Amy E Baughcum
    Center for Biobehavioral Health, Columbus Children s Research Institute, Ohio State University, Columbus, Ohio, USA
    Pediatr Blood Cancer 49:154-9. 2007
    ..As a pilot study, we developed and evaluated a daylong educational workshop on pediatric palliative care for oncology fellows...
  101. ncbi Denis Burkitt and his contribution to haematology/oncology
    Davis Coakley
    Department of Medical Gerontology, Trinity Centre for Health Sciences, St James s Hospital, Dublin 8, Ireland
    Br J Haematol 135:17-25. 2006
    ..Burkitt Lymphoma has been used as a model to advance research and treatment on a wide range of conditions in haematology and oncology. Burkitt's work in later life on dietary fibre and its implications are summarised...

Research Grants72

  1. Iron-mediated vascular disease in sickle cell disease.
    John C Wood; Fiscal Year: 2010
    ..addresses broad Challenge Area (15) Translational and specific Challenge Topic, 15- DK-106: Translating Basic Hematology Concepts...
  2. DNA Damage and Response in the Bladder Microenvironment.
    Bradley P Dixon; Fiscal Year: 2013
    ..spectrometry core, and vivarium at CCHMC as well as numerous faculty members in the Division of Experimental Hematology and Cancer Biology at CCHMC and the Departments of Cancer and Cell Biology and Molecular Genetics, Biochemistry &..
  3. Collagen X and heparan sulfate proteoglycan in the hematopoietic stem cell niche.
    ELIZABETH G SWEENEY; Fiscal Year: 2012
    ..Penn faculty members that will provide me with a unique opportunity to seek advise in skeletal/matrix biology, hematology, and B cell biology, including: Drs. Jacenko and Emerson (my mentors), Drs...
  4. Hepcidin-based screening for infantile iron deficiency
    Mark D Fleming; Fiscal Year: 2010
    ..broad Challenge Area (15): Translational Science and specific Challenge Topic, 15-DK-106: Translating Basic Hematology Concepts...
  5. Targeting CC-Chemokine Receptor 7 for the prevention of graft-versus-host disease
    JAMES M COGHILL; Fiscal Year: 2013
    ..While possessing a strong background in hematology and oncology, this work will offer Dr...
  6. Platelet TSP1 Mediates Vascular Disease and pulmonary hypertension in Sickle Cell
    Enrico M Novelli; Fiscal Year: 2013
    ..Dr. Novelli is establishing himself as an academic leader in the field of benign hematology with a specific focus on translational research in sickle cell disease and hemostasis. Dr...
  7. PRE- AND POSTGRADUATE TRAINING IN MOLECULAR HEMATOLOGY
    J Evan Sadler; Fiscal Year: 2013
    DESCRIPTION (provided by applicant): Although advances in hematology have led the way in many fields of basic and translational biomedical research, hematologic diseases remain major threats to public health...
  8. Pluripotent stem cell-derived HSCs: improvements and molecular mechanisms
    Patrick Cahan; Fiscal Year: 2013
    ..George Daley's lab at Boston Children's Hospital in the Division of Hematology/Oncology, which is also home to the laboratories of Drs...
  9. Development of a Pediatric Mylelodysplastic Syndrome Patient Registry
    DAVID A contact WILLIAMS; Fiscal Year: 2010
    ..an expert Pediatric Hematopathologist) in collaborative effort, utilizing both their clinical expertise in hematology and marrow failure disorders as well as their expertise in pediatric hematopathology. Drs...
  10. TSAD AS AN EPOR/JAK2 ADAPTOR AND ERYTHROPOIETIC REGULATOR
    DONALD JOSEPH MCCRANN; Fiscal Year: 2010
    ..and will provide me with tailored training to advance my objective to emerge as an independent investigator in hematology. EPO is a key regulator of erythroid cell formation in response to hypoxia and anemia...
  11. Implantation of physiologically functional bioengineered innervated IAS construct
    Khalil N Bitar; Fiscal Year: 2010
    ..11) Regenerative Medicine: 11-DK-101: Promote regeneration and repair in the digestive system, liver, pancreas, hematology, kidneys and urological system...
  12. Analysis of the leukemic stem cell niche in chronic myeloid leukemia
    DANIELA SANDRA KRAUSE; Fiscal Year: 2013
    ..My education as a physician scientist has focused on developing clinical expertise in hematology/oncology and clinical pathology/ transfusion medicine and basic research training on the study of leukemia...
  13. Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
    Rafael Bejar; Fiscal Year: 2013
    ..with myelodysplastic syndromes while establishing an academic career as a physician scientist in the field of hematology. The specific aims of this proposal are to: (1) study a clinically annotated cohort of 439 bone marrow samples ..
  14. NICHD Maternal Fetal Medicine Units Network
    Geeta K Swamy; Fiscal Year: 2013
    ..across the Duke University campus including pediatrics, anesthesia, infectious diseases, cardiology, hematology, pathology, genetics, pharmacology, epidemiology, research pharmacies and the Duke Translational Medicine ..
  15. Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
    ANGARA KONETI RAO; Fiscal Year: 2013
    ..inherited platelet function disorders and bleeding manifestations are widely encountered in clinical practice of hematology. In the vast majority of such patients, the molecular mechanisms are completely unknown...
  16. IL-22 in epithelial regeneration after allogeneic transplant
    Alan Hanash; Fiscal Year: 2013
    ..a five-year career plan that will build upon his background in immunology and clinical oncology/malignant hematology. Under the mentorship of Dr...
  17. Inhibiting EGFR and ER pathways in NSCLC
    Edward B Garon; Fiscal Year: 2013
    ..Garon, M.D., am an Assistant Professor of Medicine in the Division of Hematology and Oncology at UCLA with a focus in lung cancer...
  18. FASEB SRC on Hematopoietic Malignancies
    MICHELLE ALICE KELLIHER; Fiscal Year: 2011
    ..Unlike the annual American Society of Hematology Meeting, which draws well over 15,000 participants, the FASEB meeting, is restricted to 175 attendees and thus ..
  19. Immunomodulation in melanoma therapy
    NOAH A CRAFT; Fiscal Year: 2012
    ..The team of investigators is multidisciplinary and includes co-investigators from Microbiology and Immunology, Hematology-Oncology, Surgical-Oncology, Neurosurgery, and Dermatology...
  20. Aberrant activation of HGF/MET signaling as a therapeutic target in AML
    Alex Kentsis; Fiscal Year: 2013
    ..The applicant, Dr. Alex Kentsis, a pediatric hematology/oncology fellow at the Dana-Farber Cancer Institute (DFCI) has outlined a 5-year career plan that will build ..
  21. Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis
    Athan Kuliopulos; Fiscal Year: 2013
    ..and provide pilot safety/tox data (systemic parameters, liver enzymes, body weight, injection site tolerability, hematology) in 60 day repeat dose daily administration in rodents...
  22. Model systems for hematologic disorders caused by ribosomal protein deficiency
    George Thomas; Fiscal Year: 2010
    ..broad Challenge Area (15) Translational Science and specific Challenge Topic 15-DK-106: Translating basic hematology concepts...
  23. Targeting Akt Activation in CLL
    Wei Ding; Fiscal Year: 2013
    ..The Mayo Clinic Hematology program provides support for Dr...
  24. MODELING AND RESCUE OF DBA IN THE MOUSE
    Philip J Mason; Fiscal Year: 2010
    ..Challenge Area (15) "Translational Sciences and specifically the challenge topic 15-DK-106 : Translating basic hematology concepts"...
  25. Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia
    Jennifer A Woyach; Fiscal Year: 2013
    ..Dr. Jennifer Woyach is a junior faculty member in the Division of Hematology at The Ohio State University (OSU) who completed her fellowship training in June 2012...
  26. Scripps Translational Science Institute (TL1)
    ERIC JEFFREY TOPOL; Fiscal Year: 2013
    ..For the past several years the senior fellows in Hematology and Oncology, in Allergy and Immunology, and in Rheumatology have devoted the majority of the final one or two ..
  27. ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
    JEFFREY WALLACE TYNER; Fiscal Year: 2011
    ..He has studied a diverse spectrum of biological fields including botany, immunology, microbiology, and hematology/oncology...
  28. Disease-Modifying Effects of Filgastrim in a Mouse Model of AD
    Juan R Sanchez-Ramos; Fiscal Year: 2012
    ..colony stimulating factor or G-CSF) is a multi-modal hematopoietic growth factor used routinely in the hematology/oncology setting but reports of its benefits for brain diseases are appearing in the literature...
  29. Characterization of a Novel Erythropoietin Signaling Pathway
    Adam N Goldfarb; Fiscal Year: 2013
    ..This proposal is responsive to the program announcement "Stimulating Hematology Investigation: New Endeavors" (PAS-10-046)...
  30. Development of A Novel Anti-Hyperglycemic Agent
    Zhaoping Li; Fiscal Year: 2012
    ..of severe adverse events (SAEs), adverse events (AEs), any changes of vital signs, physical exams, blood hematology, chemistry, liver, renal, thyroid function tests, urine analysis and zinc, copper levels...
  31. Phase 2 Study of rAAV1-CB-hAAT for Treatment of Alpha-1 Antitrypsin Deficiency
    Jeffrey D Chulay; Fiscal Year: 2013
    ..Safety will be monitored by evaluation of adverse events, hematology and clinical chemistry parameters, histological examination of muscle biopsies, and measurement of serum ..
  32. Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease
    CAMERON JOHN TURTLE; Fiscal Year: 2012
    ..focused my clinical and laboratory training on developing a career as a physician/scientist with expertise in hematology/oncology, hematopoietic stem cell transplantation (HSCT) and human immunology...
  33. Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease
    CAMERON JOHN TURTLE; Fiscal Year: 2013
    ..focused my clinical and laboratory training on developing a career as a physician/scientist with expertise in hematology/oncology, hematopoietic stem cell transplantation (HSCT) and human immunology...
  34. Conducting Research in Pediatric Hematology/Oncology
    Debra L Friedman; Fiscal Year: 2013
    ..Vanderbilt School of Medicine and the Vanderbilt-Ingram Cancer Center and our current fellowship in Pediatric Hematology/Oncology...
  35. RESEARCH TRAINING IN HEMATOLOGY
    JOHN PATRICK SHEEHAN; Fiscal Year: 2012
    ..twenty faculty members from a total of nine Departments on campus to focus on two areas of broad importance for hematology and human disease: vascular biology and stem cell biology/hematologic malignancy...
  36. ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia
    JEFFREY WALLACE TYNER; Fiscal Year: 2013
    ..He has studied a diverse spectrum of biological fields including botany, immunology, microbiology, and hematology/oncology...
  37. Beta-catenin is a molecular target of the Fanconi anemia core complex
    Kim Hien T Dao; Fiscal Year: 2013
    ..After Internal Medicine residency training, she completed fellowship training in Hematology-Oncology at the University of California at San Diego...
  38. The Physiologic Assessment of Exercise Capacity in Pediatric Sickle Cell Anemia
    ROBERT IE LIEM; Fiscal Year: 2013
    ..is currently an Assistant Professor of Pediatrics at Northwestern and an Attending Physician in the Division of Hematology, Oncology &Stem Cell Transplant at Children's Memorial Hospital...
  39. Development of AAV vectors for the phenotypic correction of sickle cell disease
    Angela Rivers; Fiscal Year: 2013
    ..D. and M.D. programs. She is board certified in Pediatrics and Medicine, as well as board eligible in Pediatric/Hematology Oncology...
  40. A CENTER OF MOLECULAR DEVELOPMENTAL HEMATOPOIESIS
    Stuart H Orkin; Fiscal Year: 2013
    ..by applicant): A Center of Molecular Developmental Hematopoiesis: The Center of Excellence in Molecular Hematology was established ~15 years ago by the Principal Investigator (S.H. Orkin) and the co-investigator (L.I. Zon)...
  41. H3K79 Methylation in Hematopoietic Stem Cell Development and MLL-Rearranged Leuk
    Kathrin M Bernt; Fiscal Year: 2013
    ..I will build on my strong foundation in molecular biology and clinical hematology/oncology to develop expertise in epigenetic regulation, hematopoietic stem cell, and leukemia biology under the ..
  42. 2010 Gordon Research Conference on Endothelial Cell Phenotypes in Health and Dise
    Edward Conway; Fiscal Year: 2010
    ..provides a convergent interaction for investigators from such diverse fields as vascular and stem cell biology, hematology, innate immunity, infectious diseases, oncology, endocrinology, obstetrics, nephrology, neurology, ophthalmology,..
  43. The roles of lipid metabolism in the maintenance of hematopoietic stem cells
    Keisuke Ito; Fiscal Year: 2013
    ..Michael A. Brownlee (Metabolism), Chih-Hao Lee (Metabolism), David E. Avigan (Hematology/Oncology), Julie Teruya-Feldstein (Hemato- pathology), Toshio Suda (Stem Cells), Jan Vijg (Genetics), and ..
  44. Functional genomic analysis of host determinants of malaria infection
    Elizabeth Egan; Fiscal Year: 2013
    ..by taking formal courses in Parasitology, Tropical Medicine, and Bioinformatics, as well as by attending Hematology and Parasitology seminars and conferences...
  45. Diabetic Foot and Pressure Ulcer Databank
    Harold Brem; Fiscal Year: 2009
    ..the wound, a real-time graph of the wound's healing rate as measured by area, vascular testing, chemistry, hematology, microbiology laboratory values, current wound treatments, glycemic control, ambulatory status, and radiology ..
  46. Instant Pediatric POC Blood Analysis
    NEVEN KARLOVAC; Fiscal Year: 2012
    ..Accuracy, precision, and linearity of the LUCAS platform will be compared with standard laboratory hematology analyzer using unidentified blood specimens...
  47. Pathophysiology and Treatment of Fanconi's Anemia
    Markus Grompe; Fiscal Year: 2013
    ..The clinical disciplines represented by the investigators include pediatrics, medical genetics, hematology and oncology...
  48. New Mechanisms of Anti-tumor Activity of A-type PACs from Cranberries
    LAURA MARIE BYSTROM; Fiscal Year: 2012
    ..These studies will also provide medical research training in hematology/oncology and further characterize the association of cancer with iron metabolism and inflammatory states...
  49. Training program in hematologic and oncologic diseases
    Yi Zheng; Fiscal Year: 2012
    ..and 4 postdoctoral) candidates, with a emphasis on minority candidate recruitment, to specialize on one of the hematology and oncology research areas under the direct mentorship of a core mentoring faculty and an ancillary clinical ..
  50. BASIC RESEARCH IN HEMATOLOGY AND ONCOLOGY
    Marc A Shuman; Fiscal Year: 2013
    ..will be in training physician scientists to be successful in translational biomedical laboratory research in hematology and oncology...
  51. Role of the transcriptional intermediary factor TIF1g in vertebrate hematopoiesis
    Xiaoying Bai; Fiscal Year: 2011
    ..The training program in the hematology/oncology division at Children's Hospital and Harvard Medical School provides an outstanding environment for ..
  52. Regulation of Systemic RNA Interference in the Nematode C. elegans
    JENNIFER SUNG WHANGBO; Fiscal Year: 2013
    ..and Cellular Biology at Harvard University, a founding institution of modern biology;and in the Division of Hematology/Oncology at Children's Hospital Boston, which has a distinguished record for training physician-scientists...
  53. Short-Term Research Training: Students in Health Professional Schools
    John N Forrest; Fiscal Year: 2013
    ..and public health, genetics, immunobiology, internal medicine (cardiology, digestive diseases, endocrinology, hematology, infectious disease, nephrology, pulmonary, rheumatology), laboratory medicine, molecular biophysics and ..
  54. Research on the Scope and Causes of Stillbirth in the US
    Carol Hogue; Fiscal Year: 2009
    ..epidemiology/public health, pediatric/perinatal pathology, placental function, infectious diseases, hematology, genetics, birth defects, and neurology/neuropathology...
  55. Regulators of Melanocyte and Melanoma Cell Identity
    CHARLES KORE KAUFMAN; Fiscal Year: 2013
    ..Leonard Zon, in the Division of Hematology/Oncology at the Children's Hospital Boston (CHB)...
  56. Molecular mechanisms of resistance to HER2 inhibitors in breast cancer
    Brent N Rexer; Fiscal Year: 2013
    ..as a graduate student and residency training in internal medicine, has completing fellowship training in hematology/oncology, and continues as faculty in a mentored research environment...
  57. Blood Cells in Hemostasis and Thrombosis
    MARK HOWARD GINSBERG; Fiscal Year: 2012
    ..for post-doctoral scientists in the area of blood cells in hemostasis and thrombosis, based in the Division of Hematology-Oncology, to be a centerpiece in an Initiative in Vascular Biology at the University of California San Diego, La ..
  58. Training: Hematology, Immunology &Stem Cell Biology
    Frans A Kuypers; Fiscal Year: 2011
    ..by applicant): This is the second resubmission of a competitive renewal application for a post-doctoral hematology training program located at Children's Hospital Oakland Research Institute (CHORI)...
  59. The Role of Oxidative Stress in Systemic Amyloidosis
    Steven R Zeldenrust; Fiscal Year: 2010
    ..a 5-year program to promote the successful development of an independently-funded translational researcher in Hematology. The principal investigator has completed his clinical training in Internal Medicine and Hematology/Medical ..
  60. Cincinnati Center for Excellence in Molecular Hematology
    Yi Zheng; Fiscal Year: 2013
    ..The long term goal of the Cincinnati Center of Excellence in Molecular Hematology (CCEMH) is to understand and correct at the molecular level diseases with gene/environmental interactions ..
  61. 2012 CRTI Summer Workshop
    Mark Crowther; Fiscal Year: 2012
    DESCRIPTION (provided by applicant): The American Society of Hematology (ASH) Clinical Research Training Institute (CRTI) was initiated in 2003 and prepares fellows and junior faculty to conduct patient-oriented clinical research in all ..
  62. Eastern Cooperative Oncology Group (Main Institution)
    JOHN MUNN KIRKWOOD; Fiscal Year: 2013
    ..UPMC Shadyside Medical Center in 2003, with full service inpatient Medical Oncology, Surgical Oncology, and Hematology/BMT as well as a satellite Clinical Translational Science Institute (CTSI) in the outpatient Hillman Cancer ..
  63. HIV Associated Thrombocytopenia
    Zongdong Li; Fiscal Year: 2009
    ..He is currently working with Dr. Karpatkin on platelet research in the Hematology Division of the NYU Medical School. The Hematology Division has an outstanding research record...
  64. Micro-Fabricated Complete Blood Counter
    HAROLD AYLIFFE; Fiscal Year: 2007
    ..The project's long-term objective is to create an inexpensive handheld hematology analyzer with single-use disposable cartridges capable of performing a complete blood count (CBC) using a 12[..
  65. Targeting BAX Oligomerization in Hematologic Disease
    Evripidis Gavathiotis; Fiscal Year: 2010
    ..By operating at the interface of chemistry, biology, and hematology, I hope to contribute new insight into our understanding of the BAX auto- activation pathway, revealing new ..
  66. RESEARCH TRAINING IN BLOOD AND VASCULAR BIOLOGY
    Sandor Shapiro; Fiscal Year: 1999
    This application seeks to amalgamate two training grants in hematology and in hemostasis and thrombosis under the new title "Blood and Vascular Biology". The purpose of our program continues to be the training of MDs and Ph...
  67. FLVCR protein trafficking and the regulation of heme export
    JOHN GERARD QUIGLEY; Fiscal Year: 2010
    This proposal describes a 3 year research training program for the development of an academic career in hematology. The principal investigator (PI) has completed residency training in Internal Medicine and Hematology, and has been newly ..
  68. CHILDRENS CANCER GROUP
    Frederick Ruymann; Fiscal Year: 2002
    ..The Division of Hematology/Oncology is the pediatric component of the OSU-NCI funded Comprehensive Cancer Center and has an approved ..
  69. TRAINING IN RESEARCH IN RED BLOOD CELL DISEASES
    RONALD NAGEL; Fiscal Year: 2006
    A hematology research training program center on red cell diseases has existed at Einstein since 1956, first headed by Helen Ranney, then Ernst Jaffe and during the last 15 years by Ronald L. Nagel, M.D...
  70. MULTIDISCIPLINARY TRAINING IN EXPERIMENTAL HEMATOLOGY
    Scott Kaufmann; Fiscal Year: 2005
    ..Recent analysis indicates that approximately half of the recent graduates of the Mayo Clinic hematology/oncology clinical fellowship program have laboratory research commitments following fellowship...
  71. Patient-Oriented Research in Pediatric Hematology
    Ellis J Neufeld; Fiscal Year: 2010
    ..mentor for students, residents, fellows, and junior members interested in patient-oriented research in pediatric hematology and genetics...
  72. Recruitment of a translational researcher for leukemia
    Janis L Abkowitz; Fiscal Year: 2010
    DESCRIPTION (Provided by the applicant): The major goal of the Division of Hematology at the University of Washington is to recruit and support Physician/scientists to facilitate our mission of bi-directional translational research. Dr...